Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
132 questions in 24 reviews · Acute Respiratory Infections
current versionsNo studies 132 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Zinc vs placebo Risk of serious adverse events, including those that may be complications of the common cold · adults and children with colds and/or upper respiratory infections Zinc for prevention and treatment of the common cold (2024) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Vitamin A supplements vs placebo Time to occurrence of acute URTI ‐ not reported · children up to the age of 7 at risk of upper respiratory tract infection Oral vitamin A supplements to prevent acute upper respiratory tract infections in children up to seven years… (2024) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Vitamin A supplements vs placebo Number of cases with complications ‐ not reported · children up to the age of 7 at risk of upper respiratory tract infection Oral vitamin A supplements to prevent acute upper respiratory tract infections in children up to seven years… (2024) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Vitamin A supplements vs placebo Rate of hospitalisation ‐ not reported · children up to the age of 7 at risk of upper respiratory tract infection Oral vitamin A supplements to prevent acute upper respiratory tract infections in children up to seven years… (2024) · Cochrane | no estimate extracted | NR | No studies |
Paracetamol vs placebo hours Paracetamol (acetaminophen) or non‐steroidal anti‐inflammatory drugs, alone or combined, for pain relief in… (2023) · Cochrane | no estimate extracted | NR | No studies |
NSAIDs vs placebo to 7 days Paracetamol (acetaminophen) or non‐steroidal anti‐inflammatory drugs, alone or combined, for pain relief in… (2023) · Cochrane | no estimate extracted | NR | No studies |
NSAIDs vs placebo Mean time to resolution of pain Paracetamol (acetaminophen) or non‐steroidal anti‐inflammatory drugs, alone or combined, for pain relief in… (2023) · Cochrane | no estimate extracted | NR | No studies |
NSAIDs vs placebo Mean pain score at various time points Paracetamol (acetaminophen) or non‐steroidal anti‐inflammatory drugs, alone or combined, for pain relief in… (2023) · Cochrane | no estimate extracted | NR | No studies |
NSAIDs vs placebo Reconsultations Paracetamol (acetaminophen) or non‐steroidal anti‐inflammatory drugs, alone or combined, for pain relief in… (2023) · Cochrane | no estimate extracted | NR | No studies |
NSAIDs vs placebo Delayed antibiotic prescriptions Paracetamol (acetaminophen) or non‐steroidal anti‐inflammatory drugs, alone or combined, for pain relief in… (2023) · Cochrane | no estimate extracted | NR | No studies |
NSAIDs vs paracetamol Mean time to resolution of pain Paracetamol (acetaminophen) or non‐steroidal anti‐inflammatory drugs, alone or combined, for pain relief in… (2023) · Cochrane | no estimate extracted | NR | No studies |
Paracetamol vs placebo to 7 days Paracetamol (acetaminophen) or non‐steroidal anti‐inflammatory drugs, alone or combined, for pain relief in… (2023) · Cochrane | no estimate extracted | NR | No studies |
Paracetamol vs placebo Mean time to resolution of pain Paracetamol (acetaminophen) or non‐steroidal anti‐inflammatory drugs, alone or combined, for pain relief in… (2023) · Cochrane | no estimate extracted | NR | No studies |
Paracetamol vs placebo Mean pain score at various time points Paracetamol (acetaminophen) or non‐steroidal anti‐inflammatory drugs, alone or combined, for pain relief in… (2023) · Cochrane | no estimate extracted | NR | No studies |
Paracetamol vs placebo Reconsultations Paracetamol (acetaminophen) or non‐steroidal anti‐inflammatory drugs, alone or combined, for pain relief in… (2023) · Cochrane | no estimate extracted | NR | No studies |
Paracetamol vs placebo Delayed antibiotic prescriptions Paracetamol (acetaminophen) or non‐steroidal anti‐inflammatory drugs, alone or combined, for pain relief in… (2023) · Cochrane | no estimate extracted | NR | No studies |
NSAIDs vs placebo hours Paracetamol (acetaminophen) or non‐steroidal anti‐inflammatory drugs, alone or combined, for pain relief in… (2023) · Cochrane | no estimate extracted | NR | No studies |
Virus vaccines vs placebo Mortality: vaccine related and all cause ‐ not reported · young, healthy men in a military facility Vaccines for the common cold (2022) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Prone vs supine Mortality (respiratory events) ‐ not reported · acute respiratory distress in hospitalised infants and children (ARDs) Positioning for acute respiratory distress in hospitalised infants and children (2022) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Supine vs good‐lung dependent Blood gases (PaCO2) ‐ not reported · acute respiratory distress in hospitalised infants and children (ARDs) Positioning for acute respiratory distress in hospitalised infants and children (2022) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Supine vs good‐lung dependent Lung function (PaO2/FiO2 ratio) ‐ not reported · acute respiratory distress in hospitalised infants and children (ARDs) Positioning for acute respiratory distress in hospitalised infants and children (2022) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Supine vs good‐lung dependent Oxygenation index (FiO2% X MPAW/PaO2) ‐ not reported · acute respiratory distress in hospitalised infants and children (ARDs) Positioning for acute respiratory distress in hospitalised infants and children (2022) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Supine vs good‐lung dependent Potential adverse outcomes (episodes of apnoea) ‐ not reported · acute respiratory distress in hospitalised infants and children (ARDs) Positioning for acute respiratory distress in hospitalised infants and children (2022) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Supine vs good‐lung independent Mortality (respiratory events) ‐ not reported · acute respiratory distress in hospitalised infants and children Positioning for acute respiratory distress in hospitalised infants and children (2022) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Supine vs good‐lung independent Oxygen saturation (SaO2) ‐ not reported · acute respiratory distress in hospitalised infants and children Positioning for acute respiratory distress in hospitalised infants and children (2022) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Supine vs good‐lung independent Blood gases (PCO2) ‐ not reported · acute respiratory distress in hospitalised infants and children Positioning for acute respiratory distress in hospitalised infants and children (2022) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Supine vs good‐lung independent Lung function (PaO2/FiO2 ratio) ‐ not reported · acute respiratory distress in hospitalised infants and children Positioning for acute respiratory distress in hospitalised infants and children (2022) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Supine vs good‐lung independent Oxygenation index (FiO2% X MPAW/PaO2) ‐ not reported · acute respiratory distress in hospitalised infants and children Positioning for acute respiratory distress in hospitalised infants and children (2022) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Supine vs good‐lung independent Potential adverse outcomes (episodes of apnoea) ‐ not reported · acute respiratory distress in hospitalised infants and children Positioning for acute respiratory distress in hospitalised infants and children (2022) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Good‐lung independent vs good‐lung dependent positioning Mortality (respiratory events) ‐ not reported · acute respiratory distress in hospitalised infants and children Positioning for acute respiratory distress in hospitalised infants and children (2022) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Good‐lung independent vs good‐lung dependent positioning Oxygen saturation (SaO2) ‐ not reported · acute respiratory distress in hospitalised infants and children Positioning for acute respiratory distress in hospitalised infants and children (2022) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Good‐lung independent vs good‐lung dependent positioning Blood gases (PaCO2) ‐ not reported · acute respiratory distress in hospitalised infants and children Positioning for acute respiratory distress in hospitalised infants and children (2022) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Good‐lung independent vs good‐lung dependent positioning Lung function (PaO2/FiO2 ratio) ‐ not reported · acute respiratory distress in hospitalised infants and children Positioning for acute respiratory distress in hospitalised infants and children (2022) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Good‐lung independent vs good‐lung dependent positioning Oxygenation index (FiO2% X MPAW/PaO2) ‐ not reported · acute respiratory distress in hospitalised infants and children Positioning for acute respiratory distress in hospitalised infants and children (2022) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Good‐lung independent vs good‐lung dependent positioning Potential adverse outcomes (episodes of apnoea) ‐ not reported · acute respiratory distress in hospitalised infants and children Positioning for acute respiratory distress in hospitalised infants and children (2022) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Supine vs good‐lung dependent Mortality (respiratory events) ‐ not reported · acute respiratory distress in hospitalised infants and children (ARDs) Positioning for acute respiratory distress in hospitalised infants and children (2022) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Supine vs good‐lung dependent Oxygen saturation (SaO2) ‐ not reported · acute respiratory distress in hospitalised infants and children (ARDs) Positioning for acute respiratory distress in hospitalised infants and children (2022) · Cochrane | no estimate extracted | NR | No studies |
Homeopathic medicinal products vs placebo or usual care Recurrence of ARTI · children aged up to 16 years with ARTIs Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children (2022) · Cochrane | no estimate extracted | NR | No studies |
Homeopathic medicinal products vs placebo or usual care Days off work for parents · children aged up to 16 years with ARTIs Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children (2022) · Cochrane | no estimate extracted | NR | No studies |
Homeopathic medicinal products vs placebo or usual care Need for antibiotics · children aged up to 16 years with ARTIs Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children (2022) · Cochrane | no estimate extracted | NR | No studies |
Homeopathic medicinal products (non‐individualised treatment) vs placebo or usual care Disease severity · children aged up to 16 years with ARTIs Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children (2022) · Cochrane | no estimate extracted | NR | No studies |
Homeopathic medicinal products (non‐individualised treatment) vs placebo or usual care Days off work for parents · children aged up to 16 years with ARTIs Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children (2022) · Cochrane | no estimate extracted | NR | No studies |
Homeopathic medicinal products (non‐individualised treatment) vs placebo or usual care Need for antibiotics · children aged up to 16 years with ARTIs Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children (2022) · Cochrane | no estimate extracted | NR | No studies |
Active cycle of breathing techniques plus routine treatment vs routine treatment alone Duration of fever ‐ not reported · people with pneumonia Chest physiotherapy for pneumonia in adults (2022) · Cochrane | no estimate extracted | NR | No studies |
Active cycle of breathing techniques plus routine treatment vs routine treatment alone Duration of ICU stay ‐ not reported · people with pneumonia Chest physiotherapy for pneumonia in adults (2022) · Cochrane | no estimate extracted | NR | No studies |
Active cycle of breathing techniques plus routine treatment vs routine treatment alone Duration of mechanical ventilation ‐ not reported · people with pneumonia Chest physiotherapy for pneumonia in adults (2022) · Cochrane | no estimate extracted | NR | No studies |
Osteopathic manipulative treatment (OMT) plus routine treatment vs placebo plus routine treatment Duration of ICU stay ‐ not reported · people with pneumonia Chest physiotherapy for pneumonia in adults (2022) · Cochrane | no estimate extracted | NR | No studies |
Osteopathic manipulative treatment (OMT) plus routine treatment vs placebo plus routine treatment Duration of mechanical ventilation ‐ not reported · people with pneumonia Chest physiotherapy for pneumonia in adults (2022) · Cochrane | no estimate extracted | NR | No studies |
Positive expiratory pressure plus routine treatment vs routine treatment alone Cure rate ‐ not reported · people with pneumonia Chest physiotherapy for pneumonia in adults (2022) · Cochrane | no estimate extracted | NR | No studies |
Positive expiratory pressure plus routine treatment vs routine treatment alone Duration of total antibiotic therapy ‐ not reported · people with pneumonia Chest physiotherapy for pneumonia in adults (2022) · Cochrane | no estimate extracted | NR | No studies |